Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Misty Shields

Thoracic Oncology · IUSM

View

Dr. Gilberto Lopes

Thoracic Oncology · University of Miami

View

Dr. Jacob Sands

Thoracic Oncology · Dana-Farber Cancer Institute

View

Dr. Kathleen Cooney

GU Oncology · Duke

View

Dr. Rebecca Shatsky

Breast Oncology · UCSD

View

Dr. Robert Bast

Breast Oncology · MD Anderson Cancer Center

View

Dr. Julia Close

General Oncology · UF

View

Dr. Sara Tolaney

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Allison Fitzgerald

General Oncology · Dana-Farber Cancer Institute

View

Dr. Jason Mouabbi

Breast Oncology · MD Anderson Cancer Center

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    OMDr. Oriol Mirallas Vinas

    Dr. Oriol Mirallas Vinas

    Medical Oncology · Thoracic Oncology
    The University of Texas MD Anderson Cancer Center
    oriol

    Research

    Emerging Immunotherapy Targets in Early Drug Development

    2025

    Via International Journal of Molecular Sciences

    Research

    Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores

    2025

    Via The Lancet Regional Health - Europe

    Research

    Insights on Oligometastatic Non-Small-Cell Lung Cancer

    2025

    Via Cancers

    Research

    Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies

    2025

    Via Frontiers in Immunology

    Research

    Second-event endpoints (EFS2, PRFS2 and PFS2) after anti-PD-(L)1-based RCTs: a systematic review and meta-analysis

    2025

    Via Journal for Immunotherapy of Cancer

    Research

    Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy

    2025

    Via Clinical Cancer Research

    Research

    Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy response

    2025

    Via Journal for Immunotherapy of Cancer

    Research

    Histopathological, Clinical, And Molecular (HICAM) score for patients with colorectal liver metastases

    2024

    Via The British Journal of Surgery

    Research

    Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers

    2024

    Via Clinical Cancer Research

    Research

    Development of a prognostic model to predict 90-day mortality in hospitalised cancer patients (PROMISE tool): a prospective observational study

    2024

    Via The Lancet Regional Health - Europe

    Research

    The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.

    2023

    Via Therapeutic Advances in Medical Oncology

    Research

    Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Breast Cancer.

    2023

    Via Journal of Clinical Oncology

    Research

    SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

    2023

    Via The Lancet Oncology

    Research

    Nutritional status associates with immunotherapy clinical outcomes in recurrent or metastatic head and neck squamous cell carcinoma patients

    2023

    Via Oral Oncology

    Research

    Advances in immunotherapy for cervical cancer

    2023

    Via Therapeutic Advances in Medical Oncology